Accurate reconstruction of the temporal order of mutations in neoplastic progression

Kathleen Sprouffske, John W. Pepper, Carlo Maley

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

The canonical route from normal tissue to cancer occurs through sequential acquisition of somatic mutations. Many studies have constructed a linear genetic model for tumorigenesis using the genetic alterations associated with samples at different stages of neoplastic progression from cross-sectional data. The common interpretation of these models is that they reflect the temporal order within any given tumor. Linear genetic methods implicitly neglect genetic heterogeneity within a neoplasm; each neoplasm is assumed to consist of one dominant clone. We modeled neoplastic progression of colorectal cancer using an agent-based model of a colon crypt and found clonal heterogeneity within our simulated neoplasms, as observed in vivo. Just 7.3% of cells within neoplasms acquired mutations in the same order as the linear model. In 41% of the simulated neoplasms, no cells acquired mutations in the same order as the linear model. We obtained similarly poor results when comparing the temporal order with oncogenetic tree models inferred from cross-sectional data. However, when we reconstructed the cell lineage of mutations within a neoplasm using several biopsies, we found that 99.7% cells within neoplasms acquired their mutations in an order consistent with the cell lineage mutational order. Thus, we find that using cross-sectional data to infer mutational order is misleading, whereas phylogenetic methods based on sampling intratumor heterogeneity accurately reconstructs the evolutionary history of tumors. In addition, we find evidence that disruption of differentiation is likely the first lesion in progression for most cancers and should be one of the few regularities of neoplastic progression across cancers.

Original languageEnglish (US)
Pages (from-to)1135-1144
Number of pages10
JournalCancer Prevention Research
Volume4
Issue number7
DOIs
StatePublished - Jul 2011
Externally publishedYes

Fingerprint

Mutation
Neoplasms
Linear Models
Cell Lineage
Genetic Heterogeneity
Genetic Models
Colorectal Neoplasms
Colon
Carcinogenesis
Clone Cells
History
Biopsy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Accurate reconstruction of the temporal order of mutations in neoplastic progression. / Sprouffske, Kathleen; Pepper, John W.; Maley, Carlo.

In: Cancer Prevention Research, Vol. 4, No. 7, 07.2011, p. 1135-1144.

Research output: Contribution to journalArticle

Sprouffske, Kathleen ; Pepper, John W. ; Maley, Carlo. / Accurate reconstruction of the temporal order of mutations in neoplastic progression. In: Cancer Prevention Research. 2011 ; Vol. 4, No. 7. pp. 1135-1144.
@article{5c27999760f44093a7052fbafe0997ac,
title = "Accurate reconstruction of the temporal order of mutations in neoplastic progression",
abstract = "The canonical route from normal tissue to cancer occurs through sequential acquisition of somatic mutations. Many studies have constructed a linear genetic model for tumorigenesis using the genetic alterations associated with samples at different stages of neoplastic progression from cross-sectional data. The common interpretation of these models is that they reflect the temporal order within any given tumor. Linear genetic methods implicitly neglect genetic heterogeneity within a neoplasm; each neoplasm is assumed to consist of one dominant clone. We modeled neoplastic progression of colorectal cancer using an agent-based model of a colon crypt and found clonal heterogeneity within our simulated neoplasms, as observed in vivo. Just 7.3{\%} of cells within neoplasms acquired mutations in the same order as the linear model. In 41{\%} of the simulated neoplasms, no cells acquired mutations in the same order as the linear model. We obtained similarly poor results when comparing the temporal order with oncogenetic tree models inferred from cross-sectional data. However, when we reconstructed the cell lineage of mutations within a neoplasm using several biopsies, we found that 99.7{\%} cells within neoplasms acquired their mutations in an order consistent with the cell lineage mutational order. Thus, we find that using cross-sectional data to infer mutational order is misleading, whereas phylogenetic methods based on sampling intratumor heterogeneity accurately reconstructs the evolutionary history of tumors. In addition, we find evidence that disruption of differentiation is likely the first lesion in progression for most cancers and should be one of the few regularities of neoplastic progression across cancers.",
author = "Kathleen Sprouffske and Pepper, {John W.} and Carlo Maley",
year = "2011",
month = "7",
doi = "10.1158/1940-6207.CAPR-10-0374",
language = "English (US)",
volume = "4",
pages = "1135--1144",
journal = "Cancer Prevention Research",
issn = "1940-6207",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - Accurate reconstruction of the temporal order of mutations in neoplastic progression

AU - Sprouffske, Kathleen

AU - Pepper, John W.

AU - Maley, Carlo

PY - 2011/7

Y1 - 2011/7

N2 - The canonical route from normal tissue to cancer occurs through sequential acquisition of somatic mutations. Many studies have constructed a linear genetic model for tumorigenesis using the genetic alterations associated with samples at different stages of neoplastic progression from cross-sectional data. The common interpretation of these models is that they reflect the temporal order within any given tumor. Linear genetic methods implicitly neglect genetic heterogeneity within a neoplasm; each neoplasm is assumed to consist of one dominant clone. We modeled neoplastic progression of colorectal cancer using an agent-based model of a colon crypt and found clonal heterogeneity within our simulated neoplasms, as observed in vivo. Just 7.3% of cells within neoplasms acquired mutations in the same order as the linear model. In 41% of the simulated neoplasms, no cells acquired mutations in the same order as the linear model. We obtained similarly poor results when comparing the temporal order with oncogenetic tree models inferred from cross-sectional data. However, when we reconstructed the cell lineage of mutations within a neoplasm using several biopsies, we found that 99.7% cells within neoplasms acquired their mutations in an order consistent with the cell lineage mutational order. Thus, we find that using cross-sectional data to infer mutational order is misleading, whereas phylogenetic methods based on sampling intratumor heterogeneity accurately reconstructs the evolutionary history of tumors. In addition, we find evidence that disruption of differentiation is likely the first lesion in progression for most cancers and should be one of the few regularities of neoplastic progression across cancers.

AB - The canonical route from normal tissue to cancer occurs through sequential acquisition of somatic mutations. Many studies have constructed a linear genetic model for tumorigenesis using the genetic alterations associated with samples at different stages of neoplastic progression from cross-sectional data. The common interpretation of these models is that they reflect the temporal order within any given tumor. Linear genetic methods implicitly neglect genetic heterogeneity within a neoplasm; each neoplasm is assumed to consist of one dominant clone. We modeled neoplastic progression of colorectal cancer using an agent-based model of a colon crypt and found clonal heterogeneity within our simulated neoplasms, as observed in vivo. Just 7.3% of cells within neoplasms acquired mutations in the same order as the linear model. In 41% of the simulated neoplasms, no cells acquired mutations in the same order as the linear model. We obtained similarly poor results when comparing the temporal order with oncogenetic tree models inferred from cross-sectional data. However, when we reconstructed the cell lineage of mutations within a neoplasm using several biopsies, we found that 99.7% cells within neoplasms acquired their mutations in an order consistent with the cell lineage mutational order. Thus, we find that using cross-sectional data to infer mutational order is misleading, whereas phylogenetic methods based on sampling intratumor heterogeneity accurately reconstructs the evolutionary history of tumors. In addition, we find evidence that disruption of differentiation is likely the first lesion in progression for most cancers and should be one of the few regularities of neoplastic progression across cancers.

UR - http://www.scopus.com/inward/record.url?scp=79960093087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960093087&partnerID=8YFLogxK

U2 - 10.1158/1940-6207.CAPR-10-0374

DO - 10.1158/1940-6207.CAPR-10-0374

M3 - Article

C2 - 21490131

AN - SCOPUS:79960093087

VL - 4

SP - 1135

EP - 1144

JO - Cancer Prevention Research

JF - Cancer Prevention Research

SN - 1940-6207

IS - 7

ER -